| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.3 | 3e-05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |